. Author manuscript; available in PMC: 2014 Nov 1.

Published in final edited form as: Hum Immunol. 2013 Jul 19;74(11):10.1016/j.humimm.2013.07.002. doi: 10.1016/j.humimm.2013.07.002

Table 4.

Incidence of autoimmunity in Hepatitis C Virus infected patients with native (non-Orthotopic Liver Transplant) and orthotopic liver Transplan (post-Orthotopic Liver Transplant) recipients with and without fibrosis [71].

	Non-OLT		p-Value	Post-OLT		p-Value

	No Fibrosis	Fibrosis		No Fibrosis	Fibrosis

Col-I Abs+	2/25 (8%)	22/25 (88%)	0.001	2/10 (20%)	9/10 (90%)	0.001
Col-II Abs+	3/35 (12%)	20/25 (80%)	0.001	2/10 (20%)	8/10 (80%)	0.001
Col-IV Abs+	2/25 (8%)	3/25 (12%)	0.86	1/10 (10%)	1/10 (10%)	1
Col-V Abs+	3/25 (12%)	20/25 (80%)	0.001	3/10 (30%)	9/10 (90%)	0.001